BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAH4 Class: Convertible Debt

BAKER BROS. ADVISORS LP's Holding History (CIK: 0001263508)

Note: Option positions (PUT/CALL) are excluded.

Q3 2021
Shares 4,500,000 Value ($000) $4,611 Avg Close — Range —
Q2 2021
Shares 15,000,000 Value ($000) $15,566 Avg Close — Range —
Q1 2021
Shares 15,000,000 Value ($000) $15,299 Avg Close — Range —
Q4 2020
Shares 15,000,000 Value ($000) $16,033 Avg Close — Range —
Q3 2020
Shares 15,000,000 Value ($000) $15,650 Avg Close — Range —
Q2 2020
Shares 15,000,000 Value ($000) $18,340 Avg Close — Range —
Q1 2020
Shares 15,000,000 Value ($000) $15,576 Avg Close — Range —
Q4 2019
Shares 15,000,000 Value ($000) $15,841 Avg Close — Range —
Q3 2019
Shares 15,000,000 Value ($000) $14,722 Avg Close — Range —
Q2 2019
Shares 15,000,000 Value ($000) $15,566 Avg Close — Range —
Q1 2019
Shares 15,000,000 Value ($000) $15,385 Avg Close — Range —
Q4 2018
Shares 15,000,000 Value ($000) $14,911 Avg Close — Range —
Q3 2018
Shares 15,000,000 Value ($000) $15,818 Avg Close — Range —
Q2 2018
Shares 15,000,000 Value ($000) $15,198 Avg Close — Range —
Q1 2018
Shares 15,000,000 Value ($000) $14,099 Avg Close — Range —
Q4 2017
Shares 15,000,000 Value ($000) $14,928 Avg Close — Range —
Q3 2017
Shares 15,000,000 Value ($000) $15,193 Avg Close — Range —